115 related articles for article (PubMed ID: 11357955)
1. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis.
Flowers JM; Powell JF; Leigh PN; Andersen P; Shaw CE
Ann Neurol; 2001 May; 49(5):643-9. PubMed ID: 11357955
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis.
Aoki M; Lin CL; Rothstein JD; Geller BA; Hosler BA; Munsat TL; Horvitz HR; Brown RH
Ann Neurol; 1998 May; 43(5):645-53. PubMed ID: 9585360
[TBL] [Abstract][Full Text] [Related]
3. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis.
Lin CL; Bristol LA; Jin L; Dykes-Hoberg M; Crawford T; Clawson L; Rothstein JD
Neuron; 1998 Mar; 20(3):589-602. PubMed ID: 9539131
[TBL] [Abstract][Full Text] [Related]
4. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
5. A quantitative regional expression profile of EAAT2 known and novel splice variants reopens the question of aberrant EAAT2 splicing in disease.
Lauriat TL; Richler E; McInnes LA
Neurochem Int; 2007 Jan; 50(1):271-80. PubMed ID: 17050039
[TBL] [Abstract][Full Text] [Related]
6. Increased glutamine synthetase but normal EAAT2 expression in platelets of ALS patients.
Bos IW; Hoogland G; Meine Jansen CF; Willigen Gv; Spierenburg HA; van den Berg LH; de Graan PN
Neurochem Int; 2006 Mar; 48(4):306-11. PubMed ID: 16426705
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of glutamate transporter EAAT2 RNA in neocortex and hippocampus of temporal lobe epilepsy patients.
Hoogland G; van Oort RJ; Proper EA; Jansen GH; van Rijen PC; van Veelen CW; van Nieuwenhuizen O; Troost D; de Graan PN
Epilepsy Res; 2004; 59(2-3):75-82. PubMed ID: 15246112
[TBL] [Abstract][Full Text] [Related]
8. Increased RNA editing in EAAT2 pre-mRNA from amyotrophic lateral sclerosis patients: involvement of a cryptic polyadenylation site.
Flomen R; Makoff A
Neurosci Lett; 2011 Jun; 497(2):139-43. PubMed ID: 21569822
[TBL] [Abstract][Full Text] [Related]
9. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the glutamate transporter gene EAAT2 in European ALS patients.
Jackson M; Steers G; Leigh PN; Morrison KE
J Neurol; 1999 Dec; 246(12):1140-4. PubMed ID: 10653305
[TBL] [Abstract][Full Text] [Related]
11. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex.
Bristol LA; Rothstein JD
Ann Neurol; 1996 May; 39(5):676-9. PubMed ID: 8619555
[TBL] [Abstract][Full Text] [Related]
12. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls.
Honig LS; Chambliss DD; Bigio EH; Carroll SL; Elliott JL
Neurology; 2000 Oct; 55(8):1082-8. PubMed ID: 11071482
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of the glutamate transporter EAAT2b in neurological disease.
Maragakis NJ; Dykes-Hoberg M; Rothstein JD
Ann Neurol; 2004 Apr; 55(4):469-77. PubMed ID: 15048885
[TBL] [Abstract][Full Text] [Related]
14. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals.
Meyer T; Fromm A; Münch C; Schwalenstöcker B; Fray AE; Ince PG; Stamm S; Grön G; Ludolph AC; Shaw PJ
J Neurol Sci; 1999 Nov; 170(1):45-50. PubMed ID: 10540035
[TBL] [Abstract][Full Text] [Related]
15. Expression of the exon 9-skipping form of EAAT2 in astrocytes of rats.
Macnab LT; Pow DV
Neuroscience; 2007 Dec; 150(3):705-11. PubMed ID: 17981401
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of metabotropic glutamate receptor 2mRNA in T cells of ALS patients.
Poulopoulou C; Davaki P; Koliaraki V; Kolovou D; Markakis I; Vassilopoulos D
Ann Neurol; 2005 Dec; 58(6):946-9. PubMed ID: 16240362
[TBL] [Abstract][Full Text] [Related]
17. Analysis of multiple exon-skipping mRNA splice variants using SYBR Green real-time RT-PCR.
Walton HS; Gebhardt FM; Innes DJ; Dodd PR
J Neurosci Methods; 2007 Mar; 160(2):294-301. PubMed ID: 17097739
[TBL] [Abstract][Full Text] [Related]
18. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
Perry TL; Krieger C; Hansen S; Eisen A
Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
[TBL] [Abstract][Full Text] [Related]
19. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
20. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.
Henkel JS; Engelhardt JI; Siklós L; Simpson EP; Kim SH; Pan T; Goodman JC; Siddique T; Beers DR; Appel SH
Ann Neurol; 2004 Feb; 55(2):221-35. PubMed ID: 14755726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
